Fibrosis: Clinical Trials

18 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 terminated. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Terminated 18

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
Rifaximin, Placebo - Liver Cirrhosis, Coagulation Disorder
Phase 4TerminatedUniversity of Roma La Sapienza202021-04-032024-10-08
Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients
Furosemide Injection, Albumin Human - Cirrhosis, Liver, Volume Overload
Phase 4TerminatedRush University Medical Center212019-12-192025-09-16
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
Obeticholic Acid (OCA), Placebo - Liver Cirrhosis, Biliary
Phase 4TerminatedIntercept Pharmaceuticals222018-06-222022-09-06
Fractional Laser Assisted Topical Anesthesia
AFXL, AHES, EMLA cream - Cicatrix
Phase 4TerminatedNetherlands Institute for Pigment Disorders32015-06-012019-03-13
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
Obeticholic Acid (OCA), Placebo - Liver Cirrhosis, Biliary
Phase 4TerminatedIntercept Pharmaceuticals3342014-12-262023-03-09
The INFECIR-2 Albumin Prevention Study
Albumin - Advanced Chronic Liver Disease, Urinary Infection
Phase 4TerminatedEASL - CLIF Consortium1362014-05-012017-05-18
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Placebo, Rifaximin - Hepatic Encephalopathy
Phase 4TerminatedBausch Health Americas, Inc.62013-04-032024-01-09
Quality of Life and Nutritional Improvements in Cirrhotic Patients
Rifaximin, Lactulose, Lactulose Placebo - Liver Cirrhosis, Hepatic Encephalopathy
Phase 4TerminatedTampa General Hospital42013-04-012013-09-23
Verapamil vs Steroid to Prevent Keloid Recurrence
Verapamil, Kenalog 10 - Keloid Scars
Phase 4TerminatedThe University of Western Australia142012-10-012015-06-10
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
Dysport (abobotulinumtoxinA), Bacteriostatic 0.9% Sodium Chloride (vehicle) - Scar
Phase 4TerminatedUniversity Hospitals Cleveland Medical Center92011-09-012022-05-26
Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Treatment with entecavir(Baraclude®) - Hepatitis B, Chronic, Liver Fibrosis
Phase 4TerminatedRWTH Aachen University72011-04-012015-09-23
Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
Lopinavir/ritonavir, Nevirapine - HIV Infections
Phase 4TerminatedGermans Trias i Pujol Hospital92008-02-012019-12-05
Sodium Restriction in the Management of Cirrhotic Ascites
Sodium restriction - Ascites
Phase 4TerminatedUniversity of Texas Southwestern Medical Center682007-10-012010-09-14
Pregabalin for Abdominal Pain From Adhesions
Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks, Placebo first followed by open label pregabalin - Abdominal Pain, Surgical Adhesions
Phase 4TerminatedHenry Ford Health System182006-03-012023-10-23
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
Cyclosporine A, Tacrolimus - Liver Transplant, Hepatitis C
Phase 4TerminatedNovartis Pharmaceuticals3612006-01-012011-12-06
Efficacy of Sprayable PEG Barrier in Gynecologic Laparoscopy
Spraygel, Control - Postoperative Adhesion, Peritoneal Adhesion, Nos
Phase 4TerminatedRadboud University Medical Center162002-10-012010-12-29
Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)
Plasmapheresis - Nephrogenic Fibrosing Dermopathy, Nephrogenic Systemic Fibrosis
Phase 4TerminatedLoma Linda University122002-02-012014-11-21
Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
Propranolol - Spironolactone - Alcoholic Cirrhosis
Phase 4TerminatedUniversity Hospital, Angers541995-04-012017-11-01

Narrower conditions

Liver Cirrhosis (6)  ·  Hypertension, Portal (3)  ·  Cicatrix (2)  ·  Hepatic Encephalopathy (2)  ·  Liver Cirrhosis, Biliary (2)  ·  Tissue Adhesions (2)  ·  Abdominal Pain (1)  ·  Ascites (1)  ·  Blood Platelet Disorders (1)  ·  Brain Diseases (1)  ·  Cholangitis (1)  ·  Edema (1)  ·  Endotoxemia (1)  ·  HIV Infections (1)

Broader conditions

Pathologic Processes (18)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Digestive System Diseases (13)  ·  Liver Diseases (10)  ·  Infections (5)  ·  Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)  ·  Blood-Borne Infections (3)  ·  Cicatrix (3)  ·  Communicable Diseases (3)  ·  Liver Cirrhosis (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Virus Diseases (3)  ·  Brain Diseases, Metabolic (2)

Interventions

Rifaximin (3)  ·  obeticholic acid (2)  ·  Albumins (1)  ·  BID protein, human (1)  ·  Carticaine (1)  ·  Cyclosporine (1)  ·  Diet, Sodium-Restricted (1)  ·  Epinephrine (1)  ·  Furosemide (1)  ·  Lactulose (1)  ·  Lidocaine (1)  ·  Lidocaine, Prilocaine Drug Combination (1)  ·  Lopinavir (1)  ·  Nevirapine (1)  ·  Plasmapheresis (1)

Sponsors

Intercept Pharmaceuticals (2)  ·  Bausch Health Americas, Inc. (1)  ·  EASL - CLIF Consortium (1)  ·  Germans Trias i Pujol Hospital (1)  ·  Henry Ford Health System (1)  ·  Loma Linda University (1)  ·  Netherlands Institute for Pigment Disorders (1)  ·  Novartis Pharmaceuticals (1)  ·  RWTH Aachen University (1)  ·  Radboud University Medical Center (1)  ·  Rush University Medical Center (1)  ·  Tampa General Hospital (1)  ·  The University of Western Australia (1)  ·  University Hospital, Angers (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

United States (10)  ·  Spain (4)  ·  Australia (3)  ·  Germany (3)  ·  Italy (3)  ·  Netherlands (3)  ·  Argentina (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Canada (2)  ·  Estonia (2)  ·  Hungary (2)  ·  Lithuania (2)  ·  Switzerland (2)  ·  Austria (1)

Top investigators

Agustin Albillos (1)  ·  Aide McCormick (1)  ·  Albert Wolkerstorfer, MD, PhD (1)  ·  Alexander Gerbes (1)  ·  Andrea de Gottardi (1)  ·  Ann L Silverman, MD (1)  ·  Carlo Alessandria (1)  ·  Christian Trautwein, Professor MD (1)  ·  Erik Ness, MD (1)  ·  Faouzi Saliba (1)  ·  Fin Stolze Larsen (1)  ·  Fiona M Wood, Professor (1)  ·  Francesco Salerno (1)  ·  Frederick Nevens (1)

Results publications

PMID 22020082, PMID 31394283, PMID 39140490